Gilead Sciences
GILD
#98
Rank
A$250.55 B
Marketcap
A$201.86
Share price
2.22%
Change (1 day)
14.11%
Change (1 year)

Gilead Sciences (GILD) - Net assets

Net assets on the balance sheet as of December 2025 : A$32.75 Billion

According to Gilead Sciences's latest financial reports the company has A$32.75 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Gilead Sciences - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$A$33.76 B9.13%
2024-12-31$A$30.94 B-7.33%
2023-12-31$A$33.39 B7.14%
2022-12-31$A$31.16 B7.27%
2021-12-31$A$29.05 B22.61%
2020-12-31$A$23.69 B-26.75%
2019-12-31$A$32.35 B5.83%
2018-12-31$A$30.56 B16.4%
2017-12-31$A$26.25 B-2.24%
2016-12-31$A$26.86 B2.39%
2015-12-31$A$26.23 B35.73%
2014-12-31$A$19.32 B46.8%
2013-12-31$A$13.16 B43.38%
2012-12-31$A$9.18 B37.12%
2011-12-31$A$6.69 B11.13%
2010-12-31$A$6.02 B-16.78%
2009-12-31$A$7.24 B14.41%
2008-12-31$A$6.32 B53.7%
2007-12-31$A$4.11 B73.71%
2006-12-31$A$2.37 B-42.71%
2005-12-31$A$4.13 B71.16%
2004-12-31$A$2.41 B79.17%
2003-12-31$A$1.34 B33.06%
2002-12-31$A$1.01 B14.39%
2001-12-31$A$0.88 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
A$118.10 B 260.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$125.68 B 283.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-A$4.68 Billion-114.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$38.43 B 17.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.54 B-61.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$26.44 B-19.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$3.94 B-87.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$27.03 B-17.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$76.27 B 132.83%๐Ÿ‡บ๐Ÿ‡ธ USA